+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia

Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia

Antimicrobial Agents and ChemoTherapy 51(4): 1573-1576

In vitro susceptibility of 58 isolates of Pichia anomala to five antifungal drugs using two broth microdilution methods (CLSI and EUCAST) was analyzed. Low susceptibility to itraconazole was observed. Fluconazole, voriconazole, amphotericin B, and caspofungin showed good antifungal activity, although relatively high drug concentrations were necessary to inhibit the isolates.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 013049228

Download citation: RISBibTeXText

PMID: 17261632

DOI: 10.1128/AAC.01038-06

Related references

Investigation of a nosocomial outbreak of fungemia caused by Candida pelliculosa (Pichia anomala) in a Korean tertiary care center. Journal of Microbiology, Immunology, and Infection 51(6): 794-801, 2017

Rapid antifungal susceptibility determination for yeast isolates by use of Etest performed directly on blood samples from patients with fungemia. Journal of Clinical Microbiology 48(6): 2205-2212, 2010

Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates. European Journal of Clinical Microbiology and Infectious Diseases 37(10): 1841-1846, 2018

An outbreak of Pichia anomala fungemia in a Brazilian pediatric intensive care unit. Infection Control and Hospital Epidemiology 26(6): 553-558, 2005

Pichia anomala (Candida pelliculosa) fungemia in a patient with sickle cell disease. Mycopathologia 176(3-4): 273-277, 2014

Genetic relatedness and antifungal susceptibility profile of Candida albicans isolates from fungaemia patients. Medical Mycology 49(3): 248-252, 2011

Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011. Antimicrobial Agents and ChemoTherapy 58(3): 1529-1537, 2014

Fungemia by Candida pelliculosa (Pichia anomala) in a neonatal intensive care unit: a possible clonal origin. Mycopathologia 175(1-2): 175-179, 2013

Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era. Mycopathologia 162(1): 45-50, 2006

Susceptibility of nosocomial isolates of Candida species to LY121019 and other antifungal agents. Diagnostic Microbiology and Infectious Disease 12(1): 1-4, 1989

Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates. Journal of Clinical Microbiology 41(11): 5233-5235, 2003

Clinical Characteristics, Laboratory Identification, and In Vitro Antifungal Susceptibility of Yarrowia (Candida) lipolytica Isolates Causing Fungemia: a Multicenter, Prospective Surveillance Study. Journal of Clinical Microbiology 53(11): 3639-3645, 2016

Effect of Antifungal Agents on Candida spp. and Pichia anomala Isolated from Oropharyngeal Candidiasis of AIDS Patients in a University Hospital in Brazil. Brazilian Journal of Infectious Diseases 2(4): 187-196, 2000

Genotyping and antifungal susceptibility profile of Dipodascus capitatus isolates causing disseminated infection in seven hematological patients of a tertiary hospital. Journal of Clinical Microbiology 42(4): 1832-1836, 2004

Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility. Journal of Clinical Microbiology 43(9): 4434-4440, 2005